Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $1.87 in the prior trading day, Esperion Therapeutics Inc. (NASDAQ: ESPR) closed at $1.95, up 4.28%. In other words, the price has increased by $4.28 from its previous closing price. On the day, 7.34 million shares were traded. ESPR stock price reached its highest trading level at $1.965 during the session, while it also had its lowest trading level at $1.71.
Ratios:
Our goal is to gain a better understanding of ESPR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.87 and its Current Ratio is at 1.29.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 20 ’23 when Warren Eric sold 742 shares for $1.25 per share. The transaction valued at 924 led to the insider holds 68,318 shares of the business.
Warren Eric sold 243 shares of ESPR for $344 on Aug 18 ’23. The Chief Commercial Officer now owns 69,060 shares after completing the transaction at $1.41 per share. On Jul 19 ’23, another insider, Warren Eric, who serves as the Chief Commercial Officer of the company, sold 106 shares for $1.58 each. As a result, the insider received 168 and left with 69,303 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ESPR now has a Market Capitalization of 369331936 and an Enterprise Value of 819551744. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.86. Its current Enterprise Value per Revenue stands at 7.045 whereas that against EBITDA is -5.274.
Stock Price History:
Over the past 52 weeks, ESPR has reached a high of $3.40, while it has fallen to a 52-week low of $0.70. The 50-Day Moving Average of the stock is -21.15%, while the 200-Day Moving Average is calculated to be 9.81%.
Shares Statistics:
The stock has traded on average 6.58M shares per day over the past 3-months and 6908910 shares per day over the last 10 days, according to various share statistics. A total of 170.42M shares are outstanding, with a floating share count of 168.54M. Insiders hold about 1.10% of the company’s shares, while institutions hold 48.26% stake in the company. Shares short for ESPR as of 1711584000 were 19922282 with a Short Ratio of 3.03, compared to 1709164800 on 16951095. Therefore, it implies a Short% of Shares Outstanding of 19922282 and a Short% of Float of 12.020000999999999.
Earnings Estimates
Esperion Therapeutics Inc. (ESPR) is presently subject to a detailed evaluation by Esperion Therapeutics, Inc. analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $32.93, with high estimates of $21.59 and low estimates of $40.41.
